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Abstract 
Subconvulsive hippocampal neural disinhibition, i.e. reduced GABAergic inhibition, has been 
implicated in neuropsychiatric disorders characterized by attentional and memory deficits, including 
schizophrenia and age-related cognitive decline. Considering that neural disinhibition may disrupt 
both intra-hippocampal processing and processing in hippocampal projection sites, we hypothesized 
that hippocampal disinhibition disrupts hippocampus-dependent memory performance and, based 
on strong hippocampo-prefrontal connectivity, also prefrontal-dependent attention. In support of 
this hypothesis, we report that acute hippocampal disinhibition by microinfusion of the GABA-A 
receptor antagonist picrotoxin in rats impaired hippocampus-dependent everyday-type rapid place 
learning performance on the watermaze delayed-matching-to-place test and prefrontal-dependent 
attentional performance on the 5-choice-serial-reaction-time test, which does not normally require 
the hippocampus. For comparison, we also examined psychosis-related sensorimotor effects, using 
startle/prepulse inhibition (PPI) and locomotor testing. Hippocampal picrotoxin moderately 
increased locomotion and slightly reduced startle reactivity, without affecting PPI. In vivo 
electrophysiological recordings in the vicinity of the infusion site showed that picrotoxin mainly 
enhanced burst firing of hippocampal neurons. In conclusion, hippocampal neural disinhibition 
disrupts hippocampus-dependent memory performance and also manifests through deficits in not 
normally hippocampus-dependent attentional performance. These behavioral deficits may reflect a 
disrupted control of burst firing, which may disrupt hippocampal processing and cause aberrant 
drive to hippocampal projection sites. 
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Introduction 
Attentional and memory deficits cause substantial functional disability and are a major treatment 
challenge in neuropsychiatric disorders, including schizophrenia and age-related cognitive decline 
(Millan et al. 2012). GABAergic inhibitory neurotransmission is important to shape brain activity, 
and subconvulsive cortico-hippocampal neural disinhibition, i.e. impaired GABAergic inhibition, 
has been implicated in neuropsychiatric disorders and associated cognitive deficits (Marin 2012). 
Here, we focus on hippocampal neural disinhibition, aiming to examine its causal contribution to 
attentional and memory deficits. Hippocampal neural disinhibition has emerged as a key 
pathophysiological feature of schizophrenia, based on consistent findings of  metabolic overactivity 
at rest and altered post-mortem markers of GABA function in the hippocampus of schizophrenia 
patients (Lisman et al. 2008; Heckers and Konradi 2014; Ruzicka et al. 2015). Hippocampal GABA 
dysfunction has also been implicated in other cognitive disorders, notably age-related cognitive 
decline, although the evidence is more preliminary than the evidence implicating GABA 
dysfunction in schizophrenia (Huang and Mucke 2012; Stanley et al. 2012; Nava-Mesa et al. 2014).   
Neural disinhibition, by disrupting balanced neural activity within the disinhibited region, 
may impair local cognitive processing. This has recently been established for prefrontal GABA 
dysfunction (Gruber et al. 2010; Enomoto et al. 2011; Paine et al. 2011; Pehrson et al. 2013; Pezze 
et al. 2014; Paine et al. 2015; Tse et al. 2015), and there is also evidence linking hippocampal neural 
disinhibition and overactivity to impaired hippocampus-dependent memory performance (Koh et al. 
2010; Murray et al. 2011; Andrews-Zwilling et al. 2012; Bakker et al. 2012 ; Caputi et al. 2012; 
Gilani et al. 2014; Lovett-Barron et al. 2014). Moreover, regional disinhibition, by causing aberrant 
drive of projections, may disrupt neural activity and cognitive processing in distal sites. Consistent 
with distal effects, rodent studies show that hippocampal disinhibition and overactivity cause 
dopamine system upregulation and associated behavioral effects (including locomotor 
hyperactivity) (Bast et al. 2001; Bast and Feldon 2003; Lodge and Grace 2011; Gilani et al. 2014), 
which – given the strong link between dopamine and psychosis (Howes and Kapur 2009) – may 
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explain the consistent correlation of hippocampal overactivity and psychosis in schizophrenia 
(Liddle et al. 1992; Schobel et al. 2009; Heckers and Konradi 2014). Considering local and distal 
effects, we hypothesized that hippocampal neural disinhibition impairs hippocampus-dependent 
memory and, based on strong hippocampo-prefrontal connectivity, also prefrontal-dependent 
cognitive function, including attention (Bast 2011). This hypothesis would explain recent imaging 
findings that intrinsic hippocampal overactivity correlates with memory and attentional deficits in 
schizophrenia (Tregellas et al. 2014). 
To test if hippocampal neural disinhibition disrupts hippocampus-dependent memory and 
prefrontal-dependent attention, we combined hippocampal neural disinhibition by local 
microinfusion of the GABA-A antagonist picrotoxin (Bast et al. 2001; Pezze et al. 2014) with 
translational tests of clinically relevant cognitive deficits in rats. Infusions targeted temporal (also 
referred to as ventral) to intermediate hippocampus, because this part of the hippocampus features 
strong hippocampo-prefrontal connectivity and corresponds to human anterior hippocampus, which 
has been implicated in schizophrenia (Bast 2011). To test for attentional deficits, we used the 5-
choice-serial-reaction-time (5CSRT) task, which has high validity to measure prefrontal-dependent 
sustained attention, as impaired in several cognitive disorders, including schizophrenia and age-
related cognitive decline (Chudasama and Robbins 2006; Lustig et al. 2013; Romberg et al. 2013), 
and requires balanced prefrontal activity (Pezze et al. 2014). To test for memory deficits, we used 
the watermaze delayed-matching-to-place (DMP) task, which requires rats to learn rapidly (within 
one trial) new place information every day and is highly dependent on hippocampal function (Steele 
and Morris 1999; Bast et al. 2009; Pezze and Bast 2012), including function of the temporal to 
intermediate hippocampus (presumably because these regions feature functional connectivity to 
frontal and subcortical sites necessary to translate hippocampal learning into performance; Bast et 
al. 2009; Bast 2011). The task resembles the everyday problem of remembering new places and 
routes, and similar human tests using virtual or real-space analogues of the watermaze reveal 
marked deficits in schizophrenia and age-related cognitive decline (Hort et al. 2007; Fajnerova et al. 
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2014). For comparison and to identify behaviorally effective doses without gross sensorimotor 
effects, we first examined effects on locomotor activity and startle prepulse inhibition (PPI), with 
locomotor hyperactivity and PPI disruption also being widely-used psychosis-related indices (Bast 
and Feldon 2003; Swerdlow et al. 2008). To examine neural changes caused by hippocampal 
GABA dysfunction, we conducted in vivo electrophysiological recordings in the vicinity of the 
infusion site (Pezze et al. 2014). Of particular interest were changes in hippocampal burst firing, 
which has been proposed to be important for hippocampus-dependent memory function (Takahashi 
and Magee 2009; Xu et al. 2012) and for driving post-synaptic targets (Lisman 1997) and has 
recently been suggested to depend critically on local GABAergic inhibition, with opto- and 
pharmacogenetic silencing of GABAergic interneurons enhancing bursting (Lovett-Barron et al. 
2012; Royer et al. 2012). 
 
 
MATERIALS AND METHODS 
Animals 
Adult male Lister hooded rats (Charles River, UK) were used for all studies: 31 for the 
sensorimotor experiments (2 to 3 months at surgery), 11 for the 5-CSRT experiment (6 to 7 months 
at surgery), 14 for the watermaze experiments (2 to 3 months at surgery) and 15 for the 
electrophysiology (2 to 3 months at time of the acute experiment).  Rats were housed in groups of 
four in two level ‘Double Decker’ cages (462 mm X 403 mm X 404 mm; Tecniplast, UK) under 
temperature- and humidity- controlled (21±1.5°C; 50±8%) conditions and alternating 12h light dark 
cycle (lights on at 0700 h). They had ad libitum access to water and food (Teklad Global 18% 
Protein Rodent Diet 2018, Harlan, UK), except for the rats used in the 5-CSRT experiment, which 
were kept on a restricted diet to keep their weight at about 85% of their projected bodyweight 
during behavioral testing. All rats were habituated to handling by the experimenters before the start 
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of any experimental procedures. All procedures were conducted in accordance with the 
requirements of the United Kingdom (UK) Animals (Scientific Procedures) Act 1986.  
 
Cannula implantation for behavioral studies 
Using stereotactic procedures described in detail previously (Pezze et al. 2014), guide cannulae 
(stainless steel, 26-gauge, protruding 8.5 mm from a plastic pedestal; Plastics One, Bilaney, UK) 
with stylets (stainless steel, 33 gauge; Plastic Ones, Bilaney, UK) protruding 0.5 mm were 
implanted into the temporal to intermediate hippocampus, with the stylets aiming at (in mm): 5.2 
posterior to bregma, ± 4.8 lateral from midline, and 6.5 ventral from dura. These coordinates were 
adapted from our previous study in Wistar rats (Bast et al. 2001) based on pilot surgeries. After 
surgery, rats were given at least 4 days of recovery before any testing. Throughout the recovery 
period, rats underwent daily health checks and were habituated to the manual restraint necessary for 
the drug microinfusions.  
At the end of the experiments, brains were perfusion-fixated and processed histologically, as 
described previously (Pezze et al. 2014), to verify placements of the infusion cannulae and map 
them onto coronal sections adapted from a rat brain stereotaxic atlas (Paxinos and Watson 1998). 
 
Microinfusions for behavioural studies 
Rats were manually restrained during the infusions. Stylets were replaced by infusion cannulae 
(protruding 0.5 mm from tip of guide cannulae, stainless steel, 33 gauge; Plastic Ones, Bilaney, 
UK), which were connected via flexible polyethylene tubing to 5-µl SGE microsyringes mounted 
on a microinfusion pump (sp200IZ, World Precision Instruments, UK). A volume of 0.5 µl/side of 
0.9 % sterile saline (as control) or of a solution of picrotoxin (C30H34O13; Sigma-Aldrich, UK) in 
saline (25-150 ng/0.5 µl/side, depending on experiment) was then infused bilaterally over 1 min. 
The picrotoxin solutions were prepared on the day of the experiments from frozen aliquots 
containing 150 ng/0.5 µl. Movement of an air bubble, trapped in the tubing, was used to monitor the 
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infusion flow. Infusion cannulae were withdrawn and replaced by stylets 60 s after completion of 
the infusion to allow for absorption of the infusion bolus. Behavioral testing started immediately 
after infusions had been completed and stylets reinserted, except for sensorimotor testing, for which 
rats were infused in pairs, one after the other, resulting in half of the rats having a delay of about 3-5 
min between the end of the infusion and the start of testing.  
In the 5CSRT and watermaze experiments, mock infusions were performed on all rats after 
pretraining to asymptotic performance levels and before the actual infusion experiments. Mock 
infusions served to habituate the rats to the infusion procedure and to verify that the infusion 
procedure itself does not interfere with task performance. Mock infusions were conducted in the 
same way as real infusions, except that the pump was not connected to the syringes.  
The picrotoxin doses used in the present study were subconvulsive, as we aimed to investigate 
the neurocognitive sequels of neural disinhibition relevant to neuropsychiatric disorders, not 
epileptic seizures. As in our previous studies involving hippocampal picrotoxin infusions (Bast et 
al. 2001), observations of the rats following infusions and between infusion days, did not reveal 
infusion-induced motor convulsions or more subtle indicators of seizure development, such as facial 
twitches, tremor, movement arrest or wet-dog shakes, which may result from higher doses of 
GABA antagonists (Bragin et al. 2009). Furthermore, our electrophysiological studies did not 
indicate electrophysiological seizure signs (see below).  
 
Startle, PPI and locomotor activity testing 
We began by examining the effects of hippocampal picrotoxin on three basic sensorimotor process, 
the acoustic startle response and prepulse inhibition (PPI) of the acoustic startle response and open-
field locomotor activity, similar to our previous studies in Wistar rats (Bast et al. 2001). First, these 
experiments allowed us to confirm suitable picrotoxin doses for use in the Lister hooded strain that 
were behaviorally effective without causing gross sensorimotor impairment. Second, disrupted PPI 
of the acoustic startle response and locomotor hyperactivity are widely-used psychosis-related 
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indices in rodent studies (Bast and Feldon 2003; Arguello and Gogos 2006). PPI of the acoustic 
startle response refers to the reduction of the startle response to an intense acoustic pulse by an 
immediately preceding weaker, non-startling, prepulse. It may reflect sensorimotor gating 
processes, which are disrupted in schizophrenia and restored by antipsychotic medication (even 
though PPI disruption is not specific to schizophrenia and the relation of PPI deficits to symptoms 
is not clear, Swerdlow et al. 2008). Startle, PPI and locomotor tests were conducted as described in 
detail previously, using between-subjects designs (Pezze et al. 2014). 
Nineteen rats, implanted with hippocampal cannulae, were used to test the effects of 
hippocampal picrotoxin on startle and PPI (test session lasted 23 min, including 5 min of 
acclimatization). On day 1, startle and PPI were measured without infusion. On day 2, startle and 
PPI were measured following infusions of saline (n=9) or 150 ng /side picrotoxin (n=10). On Day 3, 
rats were re-tested without infusion as on Day 1. 
Twenty-nine pre-implanted rats were used for locomotor testing. The same rats used for the 
startle/PPI experiments (except for two rats which fell ill) were used, one week later, to compare the 
locomotor effects of hippocampal infusion of saline (n = 6) and of 100 ng (n=5) or 150 ng 
picrotoxin (n = 6) (i.e., these rats received a total of two infusions, with some rats receiving the 
same infusion as during the startle/PPI experiment and others receiving a different infusion, so as to 
match the new infusion groups with respect to their infusion history). Consistent with previous 
experiments in Wistar rats (Bast et al. 2001), both 100 and 150 ng/side of picrotoxin increased 
locomotor activity. Therefore, we also examined the effects of lower doses, using an additional 12 
experimentally naïve rats, receiving either saline (n=4), 50 ng (n=4) or 75 ng (n=4) picrotoxin. On 
day 1, baseline locomotor activity was tested for 1 h. On day 2, following 30 min of pre-infusion 
testing, rats received infusions of saline (n=10), 50 ng (n=4), 75 ng (n=4), 100 ng (n=5) or 150 ng 
(n=6) picrotoxin and an additional 60 min of post-infusion testing. On day 3, rats were re-tested 
without infusions as on day 1. 
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The purpose of locomotor and startle/PPI testing without infusion on day 1 and 3 was to 
verify that there were no baseline differences in dependent measures between groups before 
infusions, and that any group differences were reflecting temporary infusion-induced changes. None 
of the sensorimotor measures showed any group differences on day 1 and 3 (data not shown). 
Data were analyzed using ANOVA with infusion group as between-subjects factor and 10-
min bins (locomotor activity), test block (startle), or prepulse intensity (PPI) as within-subjects 
factor. 
 
5-choice-serial-reaction-time (5-CSRT) experiment 
The 5CSRT test requires rats to sustain and divide attention across a row of five apertures to detect 
brief light flashes occurring in random order in one of the apertures and to respond to these flashes 
by nose-poking into the correct hole to receive food reward. Procedures were described in detail 
previously (Pezze et al. 2014). 
Test boxes had five holes on one side and a food magazine on the opposite wall. Nose pokes 
into holes and magazine were detected using infrared beams. Test sessions started with delivery of 
one food pellet. Rats triggered a trial by nose-poking into the magazine. The trial started after a 5 s 
delay (inter-trial interval; ITI), with a light appearing in one of the holes for a 0.5 s stimulus 
duration. If the rat nose-poked into that hole within a 5 s limited hold period (correct response), a 
reward pellet was released into the magazine. Responses in one of the unlit four holes (incorrect 
response), failure to respond within the limited hold period (omission), and responses during the ITI 
(premature response) were punished by a 5-s time-out period with the house light turned off. 
Repeated responses in the same hole (correct or incorrect) were recorded as perseverative 
responses. A new trial started 5 s after the rat entered the food magazine, either to collect the reward 
or after the 5-s time-out. Test sessions consisted of 100 trials or lasted 30 min, whichever was 
shorter. Each rat had only one test session per day.  
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The main measures of attention were: % accuracy ([correct responses / (correct responses + 
incorrect responses)] * 100%), reflecting errors of commission due to faulty stimulus detection, and 
% omissions ([omissions / (correct responses + incorrect responses + omissions)] * 100%), which 
may reflect failure to detect the stimulus. As measures of response control, we analyzed % 
premature responses ([premature responses / (correct responses + incorrect responses + omissions + 
premature responses)] * 100 %) and % perseverative responses ([perseverative responses / (correct 
responses + incorrect responses + omissions + premature responses)] * 100 %), reflecting failure to 
withhold prepotent, but inappropriate, responses. Additional measures, to control for non-specific 
motor and/or motivational changes, were: number of trials, correct response latency (mean duration 
between stimulus onset and nose poke in correct hole), and collect latency (mean duration between 
nose poke in correct hole and collection of reward in food magazine). 
Rats were pretrained before and retrained after surgery to perform at stable and high 
performance levels (at least 80 correct trials, with 80% accuracy and 20% omissions) for at least 
five consecutive days. Rats then underwent four days of testing combined with mock infusions, 
with half of the rats receiving mock infusions on day 2 and the other half on day 4. Mock infusions 
did not affect task performance (data not shown). Eleven rats were used to test the effects of 
hippocampal picrotoxin infusions in within-subjects studies, with testing order of drug doses 
counterbalanced using a Latin-square design and each infusion day preceded by a testing day 
without infusions (to assess normal performance off-drug and avoid carry-over effects). We tested 
two dose ranges, each including saline plus two picrotoxin doses. The lower dose range included 
saline, 25 and 75 ng picrotoxin per side (chosen because they were at the low end of doses causing 
moderate locomotor hyperactivity in our sensorimotor experiments). Testing this dose range in the 
first few rats indicated no substantial effect on 5CSRT performance. Therefore, we included an 
additional higher dose range, including saline, 75 ng and 150 ng per side (75 ng dose was included 
in both ranges as an internal control for reproducibility of drug effects). Of the 11 rats, 9 completed 
both dose ranges (receiving a total of six infusions, including two saline infusions), with testing at 
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the two dose ranges separated by a minimum of 4 days of testing without infusion (to re-establish a 
stable baseline) and testing order counterbalanced across rats. In addition, one rat each completed 
only the higher or lower dose range (because of illness). Thus, each dose range was tested in 10 
rats. Data were analyzed separately for both dose ranges by ANOVA, using drug dose as within-
subjects factor, followed by post-hoc comparisons using Fisher’s LSD test (which provides good 
power and, if preceded by ANOVA and if only three means are compared as in the present study, 
ensures that the familywise type-1 error rate is equal or lower than the rate for the individual 
comparison; Levin et al. 1994). 
 
Watermaze delayed-matching-to-place (DMP) experiment 
The watermaze DMP task requires rats to learn rapidly, within one trial, the daily changing place of 
a hidden platform in order to escape fficiently from a circular pool of water (Steele and Morris 
1999). The task, especially in our new modification measuring search preference on probe trials to 
assess one-trial place memory, is highly sensitive to disruption of hippocampal function (Bast et al. 
2009; Pezze and Bast 2012). Procedures were adapted from our previous study examining the 
effects of hippocampal drug microinfusions on the watermaze DMP test (Pezze and Bast 2012). 
 
Apparatus 
The watermaze consisted of a 2-m diameter white fiberglass pool, which was 60 cm high and filled 
with water up to 20 cm below the pool edge. It was positioned in a well-lit (200 lux) room, which 
contained a variety of extra-maze visual cues visible from the water surface, so as to aid spatial 
orientation, including high-contrast wall posters and three-dimensional visual cues (cupboards, a 
traffic cone, lampshades and boxes hanging from the wall) arranged at various distances from the 
pool. Four points, equally spaced along the circumference of the pool (North (N), East (E), South 
(S) and West (W); arbitrarily defined), served as start positions. The water was made opaque with 
latex (200ml; Febflor Latex Liquid, Everbuild Building Products Ltd, Leeds, UK). During testing, 
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water temperature was maintained at 25 ± 1 °C.  The rats’ only way to escape from the water was 
via a 12-cm diameter escape platform, which was hidden from the rats’ sight 1-2 cm below the 
water surface 
We used a so-called “Atlantis platform” (Spooner et al. 1994), which can be withheld at >20 
cm below the water surface, inaccessible for the rats, by a computer-controlled electromagnet for a 
predetermined time, before rising to its normal position (Med Associates Inc., St. Albans, Vermont, 
US). This allowed us to run rewarded probe trials during which the rats’ search preference for the 
zone containing the platform location was first monitored for 60 s before the platform was made 
available to reinforce spatially focused searching. 
To record the rats’ swimming behavior, a digital camera was mounted above the watermaze, 
transmitting images to a PC in the adjacent room. The PC ran a program for video capture of the 
trials (Pinnacle Studio 12, Pinnacale Systems, Corel Corporation, Ottawa, Ontario, UK) and the 
Ethovision tracking software (Version XT 7, Noldus Technology, Wageningen, The Netherlands) 
that digitizes the rats’ paths and can compute various behavioral measures, including latencies and 
path lengths to reach the platform location, and times in different areas of the pool. 
 
General testing procedure 
Rats received 4 trials a day. The platform was hidden in a new place on trial 1 of each day, 
remaining in this place for trials 2-4, on which rats could use rapidly-encoded place memory to 
reach the escape platform efficiently. Each of the four start positions around the pool (N, E, S, W) 
was used daily in an arbitrary, pre-determined, sequence to discourage egocentric strategies. 
Analysis focused on trial 2 of each day, when performance relies on place memory encoded within 
trial 1, whereas trials 3 and 4 mainly served to reinforce the task’s win-stay rule. Trial 2 was 
occasionally run as rewarded probe trial. During such probe trials, the Atlantis platform was 
withheld at the bottom of the pool for 60 s, to enable the measurement of search preference for the 
‘correct’ zone containing the platform location (see below, Performance measures), and was then 
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released automatically (i.e., independent of the rat’s behavior) in order to allow the rat to find and 
climb onto the platform and to reinforce the win-stay rule of the task, i.e. that the rat had to return to 
the correct location to escape from the pool. Each trial began with the rat being gently lowered into 
the water facing the pool wall at one of the four start positions. Ethovision tracking was triggered by 
remote control as soon as the rat was released into the water. If rats failed to reach the platform 
within 120 s, they were guided to the platform by the experimenter (i.e., 120 s was the maximum 
latency to reach the platform location). Rats were left on the platform for 30 s, before being 
removed from the pool and placed onto a towel in an opaque plastic box close to the entrance of the 
watermaze room until the start of the next trial. The center of the escape platform was either located 
on an inner (0.8 m) or outer (1.4 m) ring concentric with the pool. Rats were tested with a novel 
location each day: as each experiment involved 20 days of training or testing (eight days of 
pretraining plus two series of six days during which the effects of hippocampal drug infusions were 
tested, see below, Experimental design), 20 different locations were used (see Fig. 1C in Pezze and 
Bast, 2012). The inter-trial interval (ITI) was usually 10-30 s (i.e., as short as possible for 
convenience), but on selected test days the ITI, or retention delay, between trial 1 and 2 was 
increased to 20 min (see below, Experimental design), similar to previous studies showing 
disruptive effects of hippocampal pharmacological manipulations (Steele and Morris 1999; Pezze 
and Bast 2012). 
 
Performance measures  
Search preference in the vicinity of the platform location during probe trials was used as the main 
measure of rapid, 1-trial, place memory performance, based on evidence from our previous studies 
that search preference is more sensitive than latency and pathlength measures (including savings, 
i.e. trial 1 values – trial 2 values) to manipulations of the hippocampus (Bast et al. 2009; Pezze and 
Bast 2012 ) and to behavioral manipulations thought to affect hippocampus-dependent memory (da 
Silva et al. 2014). The main reason for the lower sensitivity of path lengths measures is that they 
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have a much higher variability (with trial 1 path lengths in particular being highly chance 
dependent) than search preference (compare da Silva et al., 2014). Therefore, since introduction of 
probe trials as part of the DMP procedure (Bast et al., 2009), we have been using search preference 
as the main performance measure in our watermaze DMP experiments (as has long been the case 
for the standard watermaze paradigm). To quantify search preference, eight 40-cm diameter 
‘virtual’ zones were defined on the inner and outer ring of the pool, so that one zone, the ‘correct’ 
zone, was concentric with the platform location, and all eight zones were non-overlapping, evenly 
spaced and symmetrically arranged. The time spent in each of these eight zones during the 60-s 
probe trial was determined automatically using the Ethovision software. From these measures, the 
‘% time spent in the correct zone’ was calculated as: (time in ‘correct zone’ [s] / time in all eight 
zones [s]) x 100 %. By chance, this value should be 100 % / 8 = 12.5 %, whereas higher values 
indicate a search preference for the correct zone. In addition, latencies and path lengths to reach the 
platform perimeter were recorded for all trials, with steep reduction from trial 1 to 2 indicating 1-
trial place memory. Path lengths have the advantage over latencies that they measure the efficiency 
in reaching the platform independent of potential drug-induced swim speed changes. Therefore, on 
infusion days, analysis focused on path lengths.  
 
Experimental design to test the effects of hippocampal picrotoxin infusions 
Fourteen rats, preimplanted with hippocampal guide cannulae, were pretrained on the task for 8 
days, using a novel location each day, before testing infusion effects. Rats were divided in two 
batches to be trained with one of two different sequences of daily platform locations, so that on each 
day two different platform locations were used for pretraining; the purpose of this was to reduce the 
risk that a day’s performance measures are biased by the properties of specific platform locations. 
The ITI between trial 1 and 2 was 10-30 s (i.e., as short as possible for convenience, because it 
reduced the time required for training) for the first four days of pretraining and 20 min for the 
remaining days. The ITIs for trials 2 to 4 were always 10-30 s for convenience. On pretraining days 
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6 and 8, trial 2 was run as probe. In addition, rats received a mock infusion immediately before trial 
1 on either day 6 or 8. Half of the rats received the mock infusion on day 6, the other half on day 8, 
with start positions and platform locations counterbalanced between the mock-infusion and no-
mock-infusion condition. As in our previous studies (Bast et al. 2009; Jackson et al. 2011; Pezze 
and Bast 2012; da Silva et al. 2014), rats showed asymptotic task performance at the end of 
pretraining, characterized by marked latency reduction from trial 1 to trial 2 and strong search 
preference on the probe trials, without any effect of  mock infusions (data not shown). 
Following pretraining, the effects of bilateral saline or picrotoxin (75 or 150 ng/side) 
infusions were then compared in a within-subjects design. Doses were chosen based on the 5CSRT 
experiments, where 150 ng caused attentional deficits, and 75 ng was without effect. Each rat 
received three doses (including saline) across three infusion days, with each infusion day preceded 
by a testing day without infusion. This series of three infusions was repeated once more (resulting 
in a total of six infusions, including two saline infusions). The values from the two series were 
averaged to obtain one single value for each infusion condition (for one rat, values for all infusion 
conditions could only be collected in one series, and, therefore, for this rat, only the values from this 
one series were considered). On infusion days, rats received hippocampal infusions immediately 
before trial 1, and trial 2 was run 20 min after trial 1 as a probe to measure search preference.  In 
both infusion series, testing order, as well as start positions and platform locations, were 
counterbalanced across the infusion conditions. The DMP task was run as during pretraining, with a 
new platform location, different from the pretraining locations, used every day. As during 
pretraining, rats continued to be trained with one of two different sequences of daily platform 
locations, so that on each day two different platform locations were used.  
 
Data analysis 
One average value for each performance measure in each infusion condition was calculated from 
the two series of infusions for each rat, before path length and search preference measures were 
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subjected to ANOVA with infusion and trials (only for path lengths) as within-subject factors. Main 
effects were examined further using Fisher’s LSD test. To test for significant one-trial place 
memory, in each infusion condition, search preference was compared to chance (12.5%) and trial 1 
and 2 path lengths were compared, using one-sample or paired sample t-tests (2-tailed), 
respectively. 
 
In vivo electrophysiology to measure the effects of hippocampal microinfusions in the vicinity 
of the infusion site 
Multi-unit and LFP activity in the vicinity of the infusion site was recorded under isofluorane 
anesthesia using a custom-made assembly of a 33-gauge stainless steel infusion cannula and an 8-
electrode (microwire) recording array. Methods were as described in detail in our previous study 
using such an infusion-recording array in the medial prefrontal cortex (Pezze et al. 2014), except 
that recording site and aspects of the data analysis were adapted for the hippocampus.  
The infusion-recording assembly (see Fig. 5A) consisted of a 33-gauge stainless steel infusion 
cannula attached to an 8-channel microwire array (eight 50-µm Teflon-coated stainless steel wires, 
with an impedance of about 100 kΩ measured at 1 kHz and arranged in one row of about 2 mm) 
with a stainless-steel groundwire (NB Labs, Texas USA). The cannula tip touched the electrodes 
and was positioned about 0.5 mm above the tips of the central electrodes. The end of the cannula 
was connected to a 1-µl syringe via flexible tubing. Infusion cannula and tubing were filled with 
picrotoxin solution or saline before the infusion-recording assembly was inserted into the brain. A 
small air bubble was trapped where the tubing was connected to the syringe, with movement of the 
bubble serving to verify a succesful infusion. To prevent leakage and drug diffusion before the 
infusion, the piston of the syringe was pulled back to draw up a 0.25-µl air ‘plug’ separating the 
infusion solution from the brain’s extracellular space. The assembly was stereotactically implanted 
into the right hippocampus, such that the electrode array was arranged perpendicular to the brain 
midline and anterior to the infusion cannula, with the cannula tip aimed at the same coordinates as 
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in the behavioral experiments (5.2 mm posterior to bregma, 4.8 mm lateral from midline, and 6.5 
mm ventral from dura).  
To record extracellular measures of neural activity, the electrode array was connected via a 
unity-gain multi-channel headstage to a multichannel preamplifier (Plexon Inc, USA), which 
amplified (1000 x) the analogue signal and band-pass filtered it into multi-unit spikes (250 Hz to 8 
kHz) and LFP signals (0.7 Hz to 170 Hz). The analogue signals were fed to a Multichannel 
Acquisition Processor (MAP) system (Plexon Inc, USA). Multiunit and LFP data were viewed 
online and recorded with Real-Time Acquisition System Programs for Unit Timing in Neuroscience 
(RASPUTIN) software (Plexon Inc, USA). 
After positioning the assembly and stabilization (at least 30 min), local field potential (LFP) data 
were recorded continuously and multi-unit spikes were recorded when a pre-defined amplitude 
threshold of -300 µV was crossed. Data were recorded for a 30 min baseline and a 60 min period 
following hippocampal infusion of 0.5 µl of saline (n=7) or 150 ng picrotoxin in 0.5 µl saline (n= 
8). For infusions, the piston of the 1-µl syringe was moved manually at a slow speed (approximately 
0.5 µl / min as in the behavioral studies) to remove the 0.25-µl air plug from the injector tip and 
inject 0.5 µl of saline (n=7) or of 150 ng picrotoxin in 0.5 µl saline (n= 8) into the hippocampus. 
Following completion of the recordings, the rat was killed by increasing the isofluorane level. 
The positions of the most lateral and most medial electrodes were marked by passing cathodic 
current (0.2 mA, 10 s) to deposit ferric ions, which could be revealed by the Prussian Blue Reaction 
following fixation of the brain in a 4% paraformaldehyde solution containing 4% potassium 
ferrocyanide. Locations of the marked electrode tips were mapped onto coronal sections of the rat 
brain stereotaxic atlas by Paxinos and Watson (1998). 
From the multi-unit data, firing rate and burst parameters (number of bursts, % of spikes fired as 
bursts, mean firing rate within bursts, mean burst duration, inter-burst interval) were calculated in 5-
min bins for each correctly placed electrode. Hippocampal bursts were defined as more than two 
spikes with an inter-spike interval shorter than 6 ms (Royer et al. 2012). From the LFP recordings, 
Page 17 of 46 Cerebral Cortex
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
   
18 
 
we calculated the area under the curve of the power spectral density function (AUC of PSD) from 
0.7-170 Hz as a measure of overall LFP power for every 5-min block (Pezze et al. 2014). For 
normalization to baseline, values from individual channels were divided by the average values 
obtained from the same channel during the six 5-min baseline blocks. Normalized values were 
averaged across all channels per individual rat, and these average values were used to calculate 
means for the different infusion groups. Differences between infusion groups were examined, using 
ANOVA with infusion as between- and 5-min block as within-subjects factor. 
 
 
RESULTS  
Infusion cannula placements in behavioral studies 
Infusion cannula tips were primarily placed within the temporal to intermediate hippocampus, 
within an area corresponding to 4.8-6.3 mm (5.6-6.3 mm in the Watermaze experiments) posterior 
to bregma in Paxinos and Watson (1998) (Fig. 1). In the locomotor and PPI experiments, the 
infusion sites tended to be slightly deeper than in the other two experiments, with several 
placements encroaching on the entorhinal cortex. Therefore, the locomotor and PPI effects in the 
present study may partly reflect the impact of picrotoxin within the entorhinal cortex. The 
entorhinal cortex features strong prefrontal and subcortical projections similar to temporal to 
intermediate hippocampus and previous studies indicate that stimulation or disinhibition of these 
sites have a similar impact on prefrontal cortex and subcortical sites (Lopes da Silva et al. 1990; Jay 
and Witter 1991; Gigg et al. 1994; Groenewegen et al. 1999; Mitchell et al. 2000; Floresco et al. 
2001). Visible brain damage was restricted to the area immediately surrounding the guide cannula 
and the injection site (0.5 mm below the end of the guide).  
 
Hippocampal disinhibition reduces startle, without affecting PPI, and increases locomotor 
activity 
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Hippocampal picrotoxin (150 ng/side) reduced startle reactivity on pulse alone trials, especially 
during the first test block, before startle habituation led to similarly low startle amplitude in saline 
and picrotoxin groups (main effect of infusion: F1,17=6.60, P=0.020; interaction infusion X test 
block: F2,34=6.85, P=0.003) (Fig. 2A, left). Infusions did not affect PPI at any prepulse intensity 
(main effect of infusion: F1,17=1.21, P=0.29; interaction infusion X prepulse intensity: F3,51<1) (Fig. 
2A, right). 
While all groups showed similar locomotor activity in the 30 min preceding infusions (main 
effect or interaction involving the factor infusion: both F<1), picrotoxin (50, 75, 100 or 150 ng/side) 
infusions increased locomotor activity compared to saline, especially during the first 30-40 min of 
the 60-min post-infusion testing (main effect of infusion: F4,24=6.11, P=0.002; interaction infusion 
X 10-min block: F20,120=2.86, P=0.005) (Fig. 2B). 
 
5-CSRT experiment: Hippocampal neural disinhibition causes attentional deficits 
Hippocampal picrotoxin selectively impaired attention on the 5CSRT test at the highest dose (150 
ng), as indicated by reduced accuracy (Fig. 3), without significant effects on other performance 
measures or at other doses (Table 1). Testing at the higher dose range (saline, 75 and 150 ng) 
revealed a dose-dependent reduction of % accuracy (F2,18=6.57, P=0.007), with 150 ng reducing 
accuracy as compared to saline (P=0.003) and 75 ng (P=0.012), which did not differ from saline 
(P=0.54). 
 
Watermaze DMP task: Hippocampal disinhibition impairs 1-trial place memory performance 
Hippocampal picrotoxin impaired performance based on 1-trial place memory (Fig. 4). Search 
preference during probe trials was dose-dependently reduced (F2,26=6.3, P=0.006), with search 
preference at 150 ng significantly reduced as compared to saline (P=0.002) and tending to be lower 
than at 75 ng (P=0.05), which did not significantly differ from the saline condition (P=0.15) (Fig. 
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4A). Search preference at 150 ng did not differ from chance (12.5%) (t13<1), whereas rats 
performed above chance at 75 ng (t13=2.2, P=0.04) and with saline (t13=3.5, P=0.005). 
Path-length data also supported that hippocampal picrotoxin impaired performance based on 
rapid place learning (Fig. 4B). Path length analysis revealed an infusion effect (F2,26=5.1, P=0.01), 
reflecting higher path lengths at the high picrotoxin dose, compared to saline (Saline vs. 150 ng, 
P=0.004; Saline vs. 75 ng, P=0.12; 75ng vs. 150ng, P=0.13), and a trial effect (F3,39=23.2, 
P<0.0001), reflecting path length reduction across trials. Although the dose X trial interaction was 
not significant (F6,78=1.3, P=0.29), the increase of path lengths by picrotoxin, as compared to saline, 
appeared mainly driven by a less pronounced path-length reduction between trial 1 and 2, indicating 
impaired 1-trial place memory. Consistent with this, path lengths significantly decreased from trial 
1 to 2 in the saline condition (t13=4.36, P=0.001), but not at 75 ng (t13=1.8, P=0.09) or 150 ng 
picrotoxin (t13<1). Picrotoxin infusions also numerically reduced path lengths savings from trial 1 to 
2 (trial 1 path lenghth – trial 2 path length, mean+SEM: Saline, 869.1+199.5 cm; 75 ng picrotoxin, 
487.7+299.0 cm; 150 ng picrotoxin, 148.9+356.2 cm), although this effect was not significant 
(F2,13=1.7, P=0.20). The pattern of infusion effects on latency measures was virtually identical to 
the one reported for the path length measures (data not shown). Thus, overall path length and 
latency measures support impairments in rapid place learning performance due to hippocampal 
picrotoxin infusion, although the relevant infusion effects on these measures failed to reach 
statistical significance. This is consistent with our previous studies showing that path length 
measures are less sensitive than the search preference measure to hippocampal manipulations (Bast 
et al. 2009; Pezze and Bast 2012 ) and to behavioral manipulations thought to affect hippocampus-
dependent memory (da Silva et al. 2014). 
To further characterize the nature of the impairment caused by hippocampal picrotoxin on the 
watermaze DMP test, we performed additional analyses of rats behavior during trial 1. First, during 
trial 1, rats spent a similar proportion of the trial duration (i.e., the time until rats reached the 
platform) in all 8 zones, regardless of the infusion condition [(time in all 8 zones/trial 
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duration)X100%, mean+SEM: Saline, 42.7+1.5%; 75 ng picrotoxin, 43.3+1.9%; 150 ng picrotoxin, 
38.5+3.2%; F2,26=1.2, P=0.31]. This pattern of results suggests that hippocampal neural 
disinhibition does not impair normal search behavior, consistent with informal observations of the 
rats’ behavior during the experiment. Second, we analyzed which proportion of trial-1 time spent in 
these 8 zones was spent in the zone containing the platform location on the pevious day (‘previous 
day’s zone’). Intact rats typically spend more time in the previous day’s zone than expected based 
on chance (12.5 %), indicating place memory for the previous day’s correct location acquired 
during the 4 trials completed on the previous day (Steele and Morris, 1999). If picrotoxin-infused 
rats spent more time in the previous day’s zone during trial 1, this could be taken to reflect 
perseverative behavior, which might interfere with learning of the new location. If they spent less 
time, this could reflect impaired retrieval/expression of place memory acquired during the 4 trials of 
the previous day (Steele and Morris, 1999). However, there was no significant effect of infusion on 
the percentage of time spent in the previous day’s zone during trial 1 [(time in previous day’s 
zone/total time in all 8 zones)X100%, mean+SEM: Saline, 25.3+3.0%; 75 ng picrotoxin, 
24.9+3.0%; 150 ng picrotoxin, 17.7+2.7%; F2,26=2.3, P=0.12). These data show that hippocampal 
picrotoxin did not cause perseverative behavior on the watermaze test, consistent with the 5CSRT 
data not revealing any perseverative tendencies (see Table 1). Hippocampal picrotoxin numerically 
reduced the time spent in the previous day’s zone, mainly at the higher dose. Although ANOVA did 
not reveal a significant effect of infusion (see above), search preference in the previous day’s zone 
was significantly above chance (12.5 %) following hippocampal infusion of saline and 75 ng 
picrotoxin (both t13>4.2, P<0.001), indicating memory for the previous day’s location, but only 
tended to be higher than chance following infusion of 150 ng (t13=1.9, P=0.08). Overall, this data 
support that hippocampal neural disinhibition does not markedly affect search behavior during trial 
1, although the data points to a slight (non-significant) impairment in retrieval/expression of the 
place memory acquired during the previous day’s 4 trials. 
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In vivo electrophysiology: Picrotoxin enhances hippocampal neuron firing and bursting 
The most medial and/or the most lateral electrodes were located outside of the hippocampus 
(typically one to three electrodes per rat). The data from these electrodes, which were placed just 
outside the medial or lateral boundaries of the hippocampus, were analyzed separately, providing a 
control measure for drug spread out of the hippocampus. All other electrodes were placed within the 
temporal to intermediate hippocampus (Fig. 5A). 
At electrodes placed within the hippocampus, picrotoxin (150 ng) increased the overall firing rate 
and markedly enhanced the occurrence of bursts and the proportion of spikes fired as part of bursts, 
alongside a slight increase in burst duration, but without affecting within-burst firing rate (Fig. 5B). 
Mean pre-infusion baseline values of the electrophysiological parameters analyzed did not differ 
between infusion groups (Table 2). Overall firing rates were increased by picrotoxin, as compared 
to saline, starting immediately after infusion, with firing rates in both groups converging again 
about 30 min after infusion because values in the picrotoxin group peaked between 10 and 25 min, 
while values in the saline group showed an upward drift (possibly reflecting nonspecific infusion 
effects or a baseline drift) between 15 and 25 min following infusion (interaction infusion group X 
5 min block: F17,221=1.85, P=0.02). 
The most pronounced effects of picrotoxin on hippocampal neuron firing were increases in 
the occurrence of bursts and in the proportion of spikes fired as part of bursts. Picrotoxin markedly 
increased bursts per minute, starting within 5 min and peaking around 25-30 min after infusion 
before values converged with the saline group again (interaction drug x 5 min block: F17,221=2.05, 
P=0.01). The percentage of spikes fired in bursts was also markedly increased, following a similar 
time course as bursts per minute (interaction infusion group X 5-min block: F17,221=2.96, P<0.001). 
Moreover, picrotoxin increased burst duration, starting immediately after infusion and peaking 20-
25 min later before values slowly returned to baseline (interaction infusion group X 5-min block: 
F17,221=3.42, P<0.001). Consistent with the increased burst duration, picrotoxin decreased inter-
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burst intervals (interaction infusion group x block: F17,221=1.88, P=0.02). Within burst firing rate 
was not affected by infusions (main effect or interaction involving infusion group: F<1.4, P>0.4).  
Consistent with the absence of behavioral seizure signs, LFP recordings did not show 
characteristics of hippocampal seizures that may result from convulsive doses of GABA-A 
antagonists, namely a fast sequence of so-called LFP ‘spikes’ (sharp negative LFP deflection) at a 
rate of 5-20 per s superimposed on spike-wave discharges (a high-amplitude sharp negative LFP 
deflection followed by a positive LFP wave) (Bragin et al. 2009). Overall LFP power, measured as 
the AUC of PSD, was not affected by picrotoxin (main effect: F1,13<1; interaction infusion x 5-min 
block: F17,221=1.23; P=0.24) (data not shown). 
To support the spatial selectivity of the picrotoxin effects, we analyzed the data recorded from 
electrodes placed just outside the medial or lateral boundaries of the hippocampus (i.e., in the 
surrounding thalamus or parahippocampal cortex). In contrast to the marked picrotoxin-induced 
enhancement of burst firing within the hippocampus, as reflected by significant increases in ‘bursts 
per minute’, ‘percentage of spikes fired as bursts’ and ‘burst duration’, concomitant with  a 
significant increase in overall firing rate (see above and Fig. 5B), picrotoxin did not affect these 
parameters at the misplaced electrodes just outside the hippocampus (all interactions and main 
effects involving the factor infusion, P > 0.15) (Fig. 5C). There are limitations to this analysis: i) 
the number of misplaced electrodes was small;  ii) in one rat receiving picrotoxin infusion, the only 
misplaced electrode was damaged, so that data of misplaced electrodes were only available from 
n=7 rats in the picrotoxin group; iii) in some rats, none of the few misplaced electrodes recorded 
any bursts during the baseline period, so that these rats had to be excluded from the analysis of burst 
parameters normalized to baseline, resulting in n=5 in the picrotoxin and n=6 in the saline group; 
iv) electrodes were placed in two different regions (thalamus or parahippocampal cortex). These 
factors probably contributed to higher variability of the data recorded from the misplaced 
electrodes. Nevertheless, the control data from the misplaced electrodes support that picrotoxin 
effects were largely restricted to the hippocampus. This is consistent with autoradiographic studies 
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showing that intra-hippocampally infused radiolabelled AP-5, even at the relatively high infusion 
volume of 1 µl (in the present study, we used 0.5 µl), does not substantially spread across the medial 
and lateral boundaries of the hippocampus, probably because of the densely packed fiber bundles 
surrounding the hippocampus (Morris et al. 1989; Steele and Morris 1999). 
 
 
 
DISCUSSION 
Hippocampal neural disinhibition by the GABA-A antagonist picrotoxin impaired attention, without 
affecting other behavioral measures, on the 5CSRT test  and caused deficits in  rapid place learning 
performance on the watermaze DMP test. Moreover, hippocampal disinhibition moderately 
increased locomotor activity and slightly reduced startle reactivity, leaving PPI unaffected. In vivo 
electrophysiological recordings showed that picrotoxin mainly enhanced burst firing of 
hippocampal neurons.  
 
Enhanced burst firing 
Disinhibition by picrotoxin enhanced hippocampal burst firing and concomitantly increased overall 
firing rate in acute in vivo electrophysiological experiments under anesthesia. These findings are 
consistent with the enhanced hippocampal burst firing recently reported following pharmaco- or 
optogenetic silencing of hippocampal inhibitory interneurons in vitro (Lovett-Barron et al. 2012) 
and in awake mice (Royer et al. 2012), and corroborate the important role of GABAergic inhibition 
in hippocampal burst regulation. Aberrant burst firing may substantially interfere with cognitive 
functions of the hippocampus and its projection sites, as burst firing has been implicated in the 
encoding and readout of hippocampal memory (Takahashi and Magee 2009; Xu et al. 2012) and is 
particularly effective in driving post synaptic targets (Lisman 1997). Our electrophysiological 
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findings, in conjunction with our behavioural findings, suggest that aberrant hippocampal burst 
firing causes attentional and memory deficits.  
 
Attentional deficits 
The selective attentional deficits on the 5CSRT test, indicated by reduced accuracy without changes 
in other performance measures, probably reflects disruption of extra-hippocampal processing, most 
likely in prefrontal cortex or ventral striatum through strong hippocampal functional connectivity to 
these sites (Bast 2011). Previous lesion studies suggest that the hippocampus itself plays, if at all, 
only a minor role in mediating sustained attention as measured on the 5CSRT and related tests. On 
the 5CSRT test, temporal hippocampal lesions (made after pretraining to criterion levels) mainly 
increased rats’ impulsive/premature responding, with little disruption of attentional performance, 
possibly as a side effect of increased impulsive responding, whereas septal (or dorsal) hippocampal 
lesions did not substantially affect task performance (Abela et al. 2013). Although one study 
reported persistent reductions in accuracy on the 5CSRT test following lesions to the temporal 
hippocampus (made before pretraining), these were accompanied by large increases in perseverative 
responding, with the number of premature responses not reported (Le Pen et al. 2003).  Consistent 
with hippocampal lesions disrupting aspects of inhibitory response control required on the 5CSRT 
test, rather than sustained attention, complete hippocampal lesions did not affect attentional 
performance on a prefrontal-dependent self-paced serial-reaction task requiring little impulse 
control (Burk and Mair 2001). In contrast, sustained attention is highly dependent on balanced 
prefrontal activity, with prefrontal lesions (Chudasama and Robbins 2006), functional inhibition (by 
the GABA-A agonist muscimol) or disinhibition (Pezze et al. 2014) all markedly disrupting 
attention on the 5CSRT test. Sustained attention on the 5CSRT test also requires an optimal level of 
prefrontal (Granon et al. 2000) and ventral striatal (Pezze et al. 2007) dopamine receptor 
stimulation, which may be disrupted by hippocampal neural disinhibition, given that hippocampal 
stimulation activates the meso-prefrontal-ventral striatal dopamine system (Mitchell et al. 2000; 
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Floresco et al. 2001; Peleg-Raibstein et al. 2005; Bast 2011; Lodge and Grace 2011). Future studies 
will have to clarify the extra-hippocampal, including prefrontal and ventral striatal, neural effects of 
hippocampal disinhibition. The attentional deficits following hippocampal neural disinhbition 
highlight that the cognitive impact of regional neural disinhibition can extend beyond functions 
normally depending on the disinhibited region (compare Auger and Floresco 2014). 
Contrasting with the selective reduction in accuracy following hippocampal neural disinhibition 
in the present study, attentional deficits on the 5CSRT test following lesions (Chudasama and 
Robbins 2006), as well as functional inhibition or disinhibition (Pezze et al. 2014), of the medial 
prefrontal cortex manifest as decreases in accuracy alongside increases in omissions (additionally, 
lesions and functional inhibition affect response control measures). However, experimental 
manipulations primarily targetting the afferent modulation of the prefrontal cortex have been 
reported to cause selective reductions in accuracy without increasing omissions, including selective 
manipulations of the cholinergic (McGaughy et al. 2002)  or dopaminergic (Granon et al. 2000) 
modulation of the prefrontal cortex. Selective reductions in accuracy, without increases in 
omissions, have also been reported in the triple transgenic mouse model of Alzheimer’s disease 
(Romberg et al. 2011) and the pilocarpine rat model of temporal lobe epilepsy (Faure et al. 2014), 
where the primary pathology is not within the prefrontal cortex, but in brain regions, including 
medial temporal lobe regions, that may modulate the prefrontal cortex. It is entirely consistent with 
these studies that hippocampal neural disinhibition, which increases hippocampal burst firing and, 
by way of hippocampo-prefrontal functional connectivity, would modulate prefrontal function, 
causes similar selective reductions in accuracy on the 5CSRT task. Interestingly, both the 
pilocarpine rat model (Kumar and Buckmaster 2006) and the triple transgenic mouse model of 
Alzheimer’s disease (Davis et al. 2014) show hippocampal hyperexcitability; our new finding that 
hippocampal neural disinhibition causes attentional impairments suggests that hippocampal 
hyperexcitability may contribute to the attentional deficits in these rodent models. 
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Memory deficits 
Hippocampal picrotoxin markedly disrupted rapid place learning performance on the watermaze 
DMP test, as reflected by a marked reduction of search preference for the new location, which rats 
had to learn within the first trial of the day. Previous studies suggest that performance on the 
watermaze DMP test depends on the hippocampus for the required rapid encoding of new places 
and for the translation of such rapid spatial updating into behavioral performance. The DMP test is 
disrupted by pharmacological manipulations targeting synaptic plasticity mechanisms mediated by 
NMDA (Steele and Morris 1999) and dopamine receptors (Pezze and Bast 2012) and by partial 
hippocampal lesions, including lesions restricted to temporal and intermediate hippocampus (Bast et 
al. 2009), which were targeted by the infusions in the present study. Functional inhibition targeting 
the intermediate hippocampus also disrupts task performance (McGarrity et al. 2014). The 
requirement of temporal to intermediate hippocampus probably reflects that these regions feature 
functional connectivity to frontal and subcortical sites necessary to translate hippocampal learning 
into performance, although the specific relevant brain sites remain to be determined (Bast et al. 
2009; Bast 2011). Therefore, neural disinhibition, causing aberrant neuronal bursting, may disrupt 
DMP performance by interfering with hippocampal encoding or readout of relevant place 
information or with the passing on of such information to hippocampal projection sites.   
Our finding, highlighting the importance of GABAergic inhibition for hippocampus-
dependent memory performance,  converges with recent studies in mice reporting learning-related 
increase of hippocampal inhibitory synapses (Ruediger et al. 2012) and impaired memory 
performance following disruption of hippocampal GABA neuron function by molecular-, opto- or 
pharmacogenetic approaches (Prut et al. 2010; Murray et al. 2011; Andrews-Zwilling et al. 2012; 
Caputi et al. 2012; Donato et al. 2013; Gilani et al. 2014; Lovett-Barron et al. 2014; Engin et al. 
2015; Lee et al. 2016).  Moreover, our findings support recent studies in humans and rodent models 
linking hippocampal overactivity and hyperexcitability to age-related memory deficits (Koh et al. 
2010; Bakker et al. 2012; Davis et al. 2014) and are consistent with the correlation of hippocampal 
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overactivity with memory deficits in schizophrenia (Tregellas et al. 2014). However, hippocampal 
neural disinhibition may facilitate hippocampal synaptic plasticity and, thereby, improve memory, if 
such disinhibition is finely and dynamically regulated by endogenous plasticity (Donato et al. 2013) 
or if there is a pre-existing deficit due to increased neural inhibition (Fernandez et al. 2007). 
Moreover, systemic injection of a selective inverse agonist to negatively modulate GABA-A 
receptors containing the alpha5 subunit, which are predominantly expressed in hippocampus and 
constitute about 20% of hippocampal GABA-A receptors, has been suggested to facilitate 
hippocampal plasticity and memory (Dawson et al. 2006), although transgenic reduction of alpha5 
subunit-containing GABA-A receptor expression in the hippocampus has also been reported to 
disrupt aspects of hippocampus-dependent memory (Prut et al. 2010; Engin et al. 2015). 
Interestingly, a recent study suggests that enhancing the amplitude, but not duration, of synpatic 
excitation within the prefrontal cortex (by optogenetic stimulation of glutamatergic neurons or local 
infusion of a specific AMPAkine)  enhances prefrontal-dependent recognition memory (Benn et al. 
2016). Similarly, the selective inverse agonist at alpha5-subunit containing GABA receptors may 
enhance hippocampus-dependent memory by enhancing the amplitude of hippocampal neural 
activity, while leaving the temporal pattern of neural activity largely unaffected (this is consistent 
with in vitro evoked potential findings that the drug enhances LTP induction, without affecting 
stimulation-evoked field potential bursting; Dawson et al. 2006). In contrast, hippocampal neural 
disinhibition caused by picrotoxin in the present study altered the temporal organization of 
hippocampal neural activity (enhancing burst-pattern firing). Overall, hippocampus-dependent 
memory performance appears to require hippocampal neural activity that is appropriately balanced 
by GABAergic inhibition, resembling the requirement of appropriately tuned prefrontal activity for 
prefrontal-dependent cognitive functions (Gruber et al. 2010; Pezze et al. 2014; Tse et al. 2015). 
 
Sensorimotor effects 
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Locomotor hyperactivity and reduced startle reactivity caused by hippocampal picrotoxin in Lister 
hooded rats in the present study replicate findings in Wistar rats (Bast et al. 2001). These moderate 
effects are unlikely to have interfered with performance on the cognitive tests, which is supported 
by normal response and reward-collection latencies. Locomotor hyperactivity is consistent with the 
idea that increased hippocampal neuron activity drives the dopamine system and associated 
behavioral changes, which may be relevant to psychosis (Mitchell et al. 2000; Floresco et al. 2001; 
Bast and Feldon 2003; Bast 2011; Lodge and Grace 2011; Gilani et al. 2014).  
Hippocampal picrotoxin did not affect PPI in Lister hooded rats, contrasting with the marked PPI 
disruption in Wistar rats (Bast et al. 2001). Considered together with our recent finding that 
prefrontal picrotoxin, which markedly disrupts PPI in Sprague Dawley rats (Japha and Koch 1999), 
does not affect PPI in Lister hooded rats (Pezze et al. 2014), this suggests that the forebrain 
modulation of PPI is less pronounced in Lister hooded than in other rat strains, adding to strain and 
species differences in PPI modulation (Swerdlow et al. 2008). 
 
Cognitive and behavioral impact of neural disinhibition: comparison to  inactivation and 
lesions 
The findings that hippocampal neural disinhibition disrupted hippocampus-dependent place 
learning performance on the watermaze DMP task (similar to hippocampal lesions and inactivation) 
and attentional performance on the 5CSRT test (similar to prefrontal lesion, inactivation and 
disinhibition) supports the idea that hippocampal neural disinhibition, by disrupting balanced neural 
activity locally within the hippocampus or distally within hippocampal projection sites, may disrupt 
cognitive and behavioral functions depending on the hippocampus and its projection sites, such as 
the medial prefrontal cortex (Bast 2011).  
However, other hippocampus- and prefrontal-dependent functions can be largely unaffected by 
hippocampal neural disinhibition. In the present study, hippocampal neural disinhibition did not 
affect response control on the 5CSRT test (as reflected by unchanged premature or perseverative 
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responses), which has been shown to be markedly disrupted by both prefrontal and hippocampal 
lesions and/or inactivation (Chudasama and Robbins 2006; Chudasama et al. 2012; Abela et al. 
2013; Pezze et al. 2014); similar to hippocampal neural disinhibition, prefrontal disinhibition also 
does not affect response control (Pezze et al. 2014). This suggests that response control requires 
neural activity within the hippocampo-prefrontal circuit, but not the appropriate tuning of such 
activity. In other words, response control can be sustained as long as neural activity within the 
hippocampo-prefrontal circuit is above a minimal level. 
Moreover, neural disinhibition of the (temporal) hippocampus (similar to direct chemical or 
electrical stimulation, see Bast and Feldon, 2003) enhances locomotor activity (present study; Bast 
et al. 2001), which depends on neural activity within the temporal hippocampus and is reduced by 
inactivation of this region (Bast et al. 2001b). Similarly, prefrontal neural disinhibition increases, 
whereas prefrontal functional inhibition decreases locomotor activity (Pezze et al. 2014). These 
findings suggest that neural activity within hippocampus and prefrontal cortex drives open field 
locomotor activity, with a monotonic positive relation between neural activity in these areas and 
locomotion. These locomotor effects likely reflect a positive modulation of ventral striatal 
dopamine transmission by neural activity within the hippocampo-prefrontal circuit (Karreman and 
Moghaddam 1996; Mitchell et al. 2000; Floresco et al. 2001; Bast and Feldon 2003; Lodge and 
Grace 2011). 
Overall, regional neural disinhibition can impact on cognitive and behavioral functions mediated 
by the disinhibited region and by distal brain sites with which the disinhibited region is functionally 
connected. Depending on the specific hippocampus- or prefrontal-dependent function, hippocampal 
neural disinhibition may i) have a disruptive effect (i.e., have similar effects to hippocampal and/ or 
prefrontal lesions or inactivation), ii) have no effect, or iii) enhance the function (i.e., have opposite 
effects to hippocampal or prefrontal inactivation or lesion). These different effects suggest that 
different hippocampus- and prefrontal-dependent functions show different relationships to neural 
activity within hippocampus and prefrontal cortex. In addition, the impact of hippocampal neural 
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disinhibition can extend beyond hippocampus- and prefrontal-dependent functions, reflecting, for 
example, hippocampal functional links to subcortical sites (e.g., impact on subcortical dopamine 
transmission that is thought to drive locomotor activity). 
 
Clinical relevance 
Hippocampal GABA dysfunction has been implicated in schizophrenia and age-related cognitive 
decline (Lisman et al. 2008; Huang and Mucke 2012; Stanley et al. 2012; Heckers and Konradi 
2014; Nava-Mesa et al. 2014; Ruzicka et al. 2015). Given the close link between neural activity and 
metabolic activation (Sokoloff 1981), the enhanced hippocampal mutli-unit activity caused by acute 
GABA antagonism is consistent with the hippocampal metabolic overactivity characterizing early 
stages of these disorders (Schobel et al. 2009; Bakker et al. 2012; Huang and Mucke 2012). 
Compensatory adjustments and excitotoxicity associated with long-term GABA dysfunction and 
neural overactivity may contribute to regional hypoactivity and atrophy characterizing later disease 
stages (Huang and Mucke 2012; Schobel et al. 2013; Anticevic et al. 2015), aspects of these chronic 
disorders not mimicked by acute GABA antagonism.  
The 5CSRT and DMP tests have high validity to measure deficits in attention and memory 
relevant to clinical disorders, with related human paradigms – continuous performance tests and 
place learning tests in analogues of the watermaze, respectively – revealing marked deficits in 
schizophrenia and age-related cognitive decline (Chudasama and Robbins 2006; Hort et al. 2007; 
Lustig et al. 2013; Romberg et al. 2013; Fajnerova et al. 2014). Our present findings in rats suggest 
that hippocampal neural disinhbition contributes to clinically relevant attentional and memory 
deficits. Furthermore, they support that causal relationships underly the recently reported 
correlations of hippocampal overactivity with both memory and attentional deficits in schizophrenia 
patients (Tregellas et al. 2014) and the association of hippocampal overactivity with memory 
deficits in amnestic mild cognitive impairment (Bakker et al., 2012).  
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Conclusions 
Hippocampal neural disinhibition causes dysregulation of local neuron firing characterized by 
enhanced bursting, which would be expected to disrupt hippocampal processing and cause aberrant 
drive to hippocampal projection sites. Consistently, hippocampal disinhibition disrupts 
hippocampus-dependent rapid place learning performance, as well as aspects of attentional 
performance that do not normally require the hippocampus, but are mediated by prefrontal-striatal 
mechanisms. The latter supports that hippocampal dysfunction may partly manifest through deficits 
in prefrontal-dependent function, consistent with strong hippocampo-prefrontal functional 
connectivity (Meyer-Lindenberg et al. 2005; Bast 2011). The attentional and memory deficits 
caused by hippocampal neural disinhibition, together with findings that prefrontal-cortical 
disinhibition disrupts attentional and executive functions (Gruber et al. 2010; Enomoto et al. 2011; 
Paine et al. 2011; Pehrson et al. 2013; Pezze et al. 2014; Paine et al. 2015; Tse et al. 2015), 
highlight the importance of cortico-hippocampal GABAergic inhibition for cognitive function. This 
supports that cortico-hippocampal neural disinhibition, which is a key feature of schizophrenia 
(Lisman et al. 2008; Heckers and Konradi 2014; Tse et al. 2015) and has been implicated in other 
disorders, most notably age-related cognitive decline (Huang and Mucke 2012; Stanley et al. 2012; 
Nava-Mesa et al. 2014), contributes to causing key cognitive deficits characterizing these disorders 
and, hence, is an important treatment target. 
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Table 1. Performance measures (mean±SEM) in the 5CSRT experiments  
Experiment %accuracy %omissions %premature 
responses 
%perseverative 
responses 
Number 
of trials 
Correct 
latency (s) 
Collect 
latency (s) 
Picrotoxin, 25 and 
75ng/side 
       
Saline 79.4±1.9 11.3±2.1 15.1±3.8   9.8±3.9 92.5±3.8 0.58±0.03 1.31±0.12 
25ng 81.2±2.2 10.2±2.3 11.2±1.8 11.8±3.7 94.3±3.9 0.57±0.03 1.32±0.11 
75ng 76.8±3.1 12.2±2.0 11.9±1.7   8.4±2.2 91.7±4.0 0.61±0.02 1.28±0.10 
Main effect of 
drug infusion 
F2,18=1.45, 
P=0.26 
F2,18<1 F2,18<1 F2,18=1.53, P=0.24 F2,18<1 F2,18<1 F2,18<1 
Picrotoxin, 75 and 
150ng/side 
       
Saline 81.8±1.1 14.1±3.7 12.0±1.8 7.0±1.9 96.7±1.9 0.60±0.03 1.55±0.17 
75ng 80.5±1.2 11.8±1.9 14.0±2.1 8.5±1.9 97.9±1.7 0.59±0.02 1.35±0.13 
150ng 74.9±2.8 14.4±1.7 13.0±3.8 6.4±2.1 96.1±2.5 0.64±0.05 1.50±0.18 
Main effect of 
drug infusion 
F2,18=6.57, 
P=0.007 
F2,18<1 F2,18<1 F2,18=2.78, P=0.09 F2,18<1 F2,18<1 F2,18=1.67, 
P=0.22 
 
 
 
Table 2. Pre-infusion baseline values (mean+SEM) of all electrophyisiological measures recorded from the hippocampal electrodes in the two 
prospective infusion groups  
 Overall firing 
rate (1/s) 
Bursts 
(1/min) 
% spikes 
fired in 
bursts 
Within-burst 
firing rate 
Burst 
duration 
(ms) 
Interburst 
interval (s) 
LFP 
AUC of PSD 
(µV2) 
Saline 42.1±11.8 265.5±75.5 28.8±3.9 381.3±6.1 10.1±0.5 6.6±1.7 0.0411±0.0035 
Picrotoxin (150 ng) 35.4±3.4 251.11±27.7 25.6±1.6 401.8±4.9 9.2±0.2 4.4±0.8 0.0303±0.0025 
        
Effect of infusion F1,13<1 F1,13<1 F1,13<1 F1,13=1.2, P=0.3 F1,13<1 F1,13<1 F1,13=1.4, P=0.3 
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FIGURE CAPTIONS 
FIGURE 1 Infusion cannula placements in the behavioral studies. A Cresyl violet-stained section 
showing an exemplar infusion site in the temporal hippocampus. The section was taken from a rat 
that participated in the watermaze experiment. B Approximate locations of infusion cannula tips 
(dots) in the temporal to intermediate hippocampus, depicted separately for the different 
experiments. Locations are shown on coronal plates adapted from Paxinos and Watson (1998), with 
numbers indicating distance from bregma in millimeters.  
 
FIGURE 2 Sensorimotor effects. A Hippocampal picrotoxin reduces startle reactivity, but does not 
affect PPI: Mean startle magnitude on pulse-alone trials (mean±SEM) for the three test blocks 
(block 1, 10 consecutive pulse-alone trials; block 2, 10 pulse-alone trials interspersed with 
prepulse+pulse trials; block 3, 5 consecutive pulse-alone trials) and mean %PPI at the different 
prepulse intensities following infusion of saline or 150 ng of picrotoxin. Asterisk indicates 
significant interaction infusion X test block. B Hippocampal picrotoxin increases locomotor 
activity: Locomotor activity measured as photo beam breaks (mean ± SEM) did not differ between 
groups during the 30 min preceding infusion; hippocampal picrotoxin infusions (50, 75, 150 ng per 
side) increased activity as compared to saline infusion. Asterisk indicates significant interaction 
infusion X 10-min block. 
 
FIGURE 3 Hippocampal picrotoxin causes attentional deficits on the 5CSRT test. Attention, 
measured as % accuracy ([correct responses / (correct responses + incorrect responses)] * 100 %, 
mean+SEM), was dose-dependently reduced by hippocampal picrotoxin infusion. Asterisk indicates 
significant difference as compared to saline condition. 
 
FIGURE 4 Hippocampal disinhibition impairs 1-trial place memory performance on the 
watermaze DMP test. A Percentage of time spent in the correct zone (mean+SEM) during probe 
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trials was dose-dependently reduced by hippocampal picrotoxin infusion. The asterisk indicates a 
significant difference as compared to the saline condition. The horizontal line represents chance 
performance. B Path lengths (mean±SEM) to reach the platform location were increased across all 4 
trials following infusion of picrotoxin, with the most pronounced difference on trial 2. Rats only 
showed a significant path length reduction from trial 1 to 2 (indicated by asterisk) following saline 
infusion, but not following picrotoxin infusions. 
 
FIGURE 5 Picrotoxin increases overall firing rate and markedly enhances bursting within the 
hippocampus. A Placement of infusion-electrode array assembly: The photograph on the left shows 
the assembly of infusion cannula and 8-microwire-electrode array used to measure effects of drug 
microinfusions on hippocampal neural activity. The array was arranged perpendicular to the midline 
of the brain, with the infusion cannula located just posterior to the center of the array. The 
photograph on the right shows an exemplar coronal section through the hippocampus with markings 
(highlighted by white arrow heads) from the most medial and most lateral electrodes of the array. In 
this case, the two most laterally located electrodes were located outside of the hippocampus. 
Underneath the photographs, the approximate locations of markings from the most medial (black 
dots) and most lateral (gray dots) electrodes for all rats included in the electrophysiological studies 
are shown on coronal plates from Paxinos and Watson (1998), with numbers indicating distance 
from bregma in millimeters. Based on the locations of the markings, the most medial and/or the 
most lateral electrodes, typically one to three electrodes per rat, were located outside the 
hippocampus in all rats. Data recorded from electrodes placed outside hippocampus were analyzed 
separately from data recorded from the hippocampus, providing a control measure for drug spread 
outside the hippocampus. B Data recorded at electrodes placed within the hippocampus: Time 
courses of multi-unit measures during baseline recordings and following infusion of picrotoxin or 
saline. All values are normalized to baseline (average of the six baseline 5-min blocks) and are 
presented as means±SEM. The stippled horizontal line indicates baseline and the arrow indicates 
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the time of infusion. C Data recorded at electrodes placed just outside hippocampus: Time courses 
of the multi-unit measures (all values normalized to baseline, means±SEM) that showed marked 
effects of picrotoxin infusion when recorded within hippocampus. Note absence of any clear 
picrotoxin effect, supporting that drug spread was largely restricted to within the hippocampus. 
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FIGURE 1 Infusion cannula placements in the behavioral studies. A Cresyl violet-stained section showing an 
exemplar infusion site in the temporal hippocampus. The section was taken from a rat that participated in 
the watermaze experiment. B Approximate locations of infusion cannula tips (dots) in the temporal to 
intermediate hippocampus, depicted separately for the different experiments. Locations are shown on 
coronal plates adapted from Paxinos and Watson (1998), with numbers indicating distance from bregma in 
millimeters.  
Fig. 1  
83x46mm (300 x 300 DPI)  
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FIGURE 2 Sensorimotor effects. A Hippocampal picrotoxin reduces startle reactivity, but does not affect PPI: 
Mean startle magnitude on pulse-alone trials (mean±SEM) for the three test blocks (block 1, 10 consecutive 
pulse-alone trials; block 2, 10 pulse-alone trials interspersed with prepulse+pulse trials; block 3, 5 
consecutive pulse-alone trials) and mean %PPI at the different prepulse intensities following infusion of 
saline or 150 ng of picrotoxin. Asterisk indicates significant interaction infusion X test block. B Hippocampal 
picrotoxin increases locomotor activity: Locomotor activity measured as photo beam breaks (mean ± SEM) 
did not differ between groups during the 30 min preceding infusion; hippocampal picrotoxin infusions (50, 
75, 150 ng per side) increased activity as compared to saline infusion. Asterisk indicates significant 
interaction infusion X 10-min block.  
Fig. 2  
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FIGURE 3 Hippocampal picrotoxin causes attentional deficits on the 5CSRT test. Attention, measured as % 
accuracy ([correct responses / (correct responses + incorrect responses)] * 100 %, mean+SEM), was dose-
dependently reduced by hippocampal picrotoxin infusion. Asterisk indicates significant difference as 
compared to saline condition.  
Fig. 3  
77x133mm (300 x 300 DPI)  
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FIGURE 4 Hippocampal disinhibition impairs 1-trial place memory performance on the watermaze DMP test. 
A Percentage of time spent in the correct zone (mean+SEM) during probe trials was dose-dependently 
reduced by hippocampal picrotoxin infusion. The asterisk indicates a significant difference as compared to 
the saline condition. The horizontal line represents chance performance. B Path lengths (mean±SEM) to 
reach the platform location were increased across all 4 trials following infusion of picrotoxin, with the most 
pronounced difference on trial 2. Rats only showed a significant path length reduction from trial 1 to 2 
(indicated by asterisk) following saline infusion, but not following picrotoxin infusions.  
Fig. 4  
83x91mm (300 x 300 DPI)  
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FIGURE 5 Picrotoxin increases overall firing rate and markedly enhances bursting within the hippocampus. A 
Placement of infusion-electrode array assembly: The photograph on the left shows the assembly of infusion 
cannula and 8-microwire-electrode array used to measure effects of drug microinfusions on hippocampal 
neural activity. The array was arranged perpendicular to the midline of the brain, with the infusion cannula 
located just posterior to the center of the array. The photograph on the right shows an exemplar coronal 
section through the hippocampus with markings (highlighted by white arrow heads) from the most medial 
and most lateral electrodes of the array. In this case, the two most laterally located electrodes were located 
outside of the hippocampus. Underneath the photographs, the approximate locations of markings from the 
most medial (black dots) and most lateral (gray dots) electrodes for all rats included in the 
electrophysiological studies are shown on coronal plates from Paxinos and Watson (1998), with numbers 
indicating distance from bregma in millimeters. Based on the locations of the markings, the most medial 
and/or the most lateral electrodes, typically one to three electrodes per rat, were located outside the 
hippocampus in all rats. Data recorded from electrodes placed outside hippocampus were analyzed 
separately from data recorded from the hippocampus, providing a control measure for drug spread outside 
the hippocampus. B Data recorded at electrodes placed within the hippocampus: Time courses of multi-unit 
measures during baseline recordings and following infusion of picrotoxin or saline. All values are normalized 
to baseline (average of the six baseline 5-min blocks) and are presented as means±SEM. The stippled 
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horizontal line indicates baseline and the arrow indicates the time of infusion. C Data recorded at electrodes 
placed just outside hippocampus: Time courses of the multi-unit measures (all values normalized to 
baseline, means±SEM) that showed marked effects of picrotoxin infusion when recorded within 
hippocampus. Note absence of any clear picrotoxin effect, supporting that drug spread was largely restricted 
to within the hippocampus.  
Fig. 5  
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